Click Here for Youtube Updates!

Follow Dr. Kin on Twitter!

Due to an error, potentially a timed-out connection to Twitter, this user's tweets are unable to be displayed.

Facebook Updates

Mistletoe (also known as Viscum album) is widely used in cancer treatments in Europe. Mistletoe extract has even been in the news since actress Suzanne Somers announced that she is using it as an adjunctive therapy to fight breast cancer following lumpectomy and radiation.

In the May issue of the peer-reviewed journal Alternative Therapies in Health and Medicine. The study showed that individuals who took mistletoe extract in addition to their standard medical treatment for cancer lived 40% longer.

Research indicates that mistletoe extract is most effective when used in conjunction with standard medical cancer care for the treatment of solid tumors such as breast, liver, and colon cancers.

Dr. Kin, uses Mistletoe into the treatment protocol for several cancer types. Patients are instructed as to the appropriate use, dosing schedule, and length of treatment for this product. Generally, subcutaneous injections (under the skin) are administered 3 times per week until the desired effect is attained. Mistletoe can be used along with standard cancer treatment (i.e. surgery, radiation, chemotherapy) and has not been shown to cause any significant side effects or complications.


A Published Study:

Altern Ther Health Med. 2001 May-Jun;7(3):57-66, 68-72, 74-6 passim.

Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.

Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R.

Institute for Preventive Medicine, European Center for Peace and Development, United Nations, Heidelberg, Germany.


In anthroposophical medicine, total extracts of Viscum album (mistletoe) have been developed to treat cancer patients. The oldest such product is Iscador. Although Iscador is regarded as a complementary cancer therapy, it is the most commonly used oncological drug in Germany.

To determine whether Iscador treatment prolongs survival time of patients with carcinoma of the colon, rectum, or stomach; breast carcinoma with or without axillary or remote metastases; or small cell or non-small-cell bronchogenic carcinoma; and to explore synergies between Iscador treatment and psychosomatic self-regulation.

Prospective nonrandomized and randomized matched-pair studies nested within a cohort study.

General community in Germany.

10,226 cancer patients involved in a prospective long-term epidemiological cohort study, including 1668 patients treated with Iscador and 8475 who had taken neither Iscador nor any other mistletoe product (control patients).


Survival time.

In the nonrandomized matched-pair study, survival time of patients treated with Iscador was longer for all types of cancer studied. In the pool of 396 matched pairs, mean survival time in the Iscador groups (4.23 years) was roughly 40% longer than in the control groups (3.05 years; P < .001). Synergies between Iscador treatment and self-regulation manifested in a longer survival advantage for Iscador patients with good self-regulation (56% relative to control group; P = .03) than for patients with poor self-regulation. Results of the 2 randomized matched-pair studies largely confirmed the results of the non-randomized studies.

Iscador treatment can achieve a clinically relevant prolongation of survival time of cancer patients and appears to stimulate self-regulation.


To book an appointment call 587-360-1100
He is your Airdrie Naturopath and serving the surrounding, Olds, Didsbury, Drumheller, Cochrane, Calgary area.

Dr. Kin Leung, B.Sc., N.D., CCT, CPCC, FABNO
Naturopathic Fundamentals Wellness Clinic
Unit 6104, 403 MacKenzie Way SW
Airdrie, AB
T4E 3V7

(587) 360-1100